Federal Agency · National Institutes of Health
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
Last updated: November 8, 2026
Posted November 22, 2024
- Who can apply
- Educational institutions, government agencies and municipalities, nonprofit organizations, and eligible organizations
- Amount
- Not specified — see source
- Deadline
- December 23, 2027 · 409 days remaining
- Where
- Nationwide
- Status
- Open
The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in product development and entrepreneurship.
This specific Catalyze Product Definition initiative will provide the early stage translational support needed for the activities required to identify and characterize potential therapeutic candidates and combination products to treat HLBS diseases and disorders. This initiative has a companion initiative that supports development of devices and diagnostics and is also part of a suite of innovation grants to advance projects to the point where they can meet the entry criteria for the NHLBI Catalyze Preclinical Program.
Program Details
National Institutes of Health is a federal agency that offers the Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed) grant program to support research innovation. This funding opportunity is available nationally and is administered by National Institutes of Health through Grants.gov. Organizations seeking funding for research innovation should review the details below and confirm their eligibility before preparing an application.
Eligibility
Eligible applicants include educational institutions, government agencies and municipalities, nonprofit organizations, and eligible organizations. Organizations that meet the eligibility criteria are encouraged to apply and to review the full program guidelines before submission. Because eligibility rules and funding priorities can change between cycles, applicants should always confirm the current requirements with National Institutes of Health or on Grants.gov before investing time in an application.
Funding and Timeline
The application deadline is December 23, 2027 (409 days remaining). Applicants should allow sufficient time to gather required documentation, including organizational information, project descriptions, budgets, and supporting materials as specified in the program guidelines. Submitting a complete application well ahead of the deadline reduces the risk of disqualification on technical or administrative grounds.
Program Focus
This grant supports research innovation. This grant is associated with NAICS industry classifications: 541714, 621111, 621112, 622, 485. Organizations operating in these sectors are encouraged to review eligibility. Funded projects are expected to demonstrate measurable outcomes aligned with the program's stated objectives. Grant recipients may be required to submit progress reports and final evaluations as a condition of the award, and to retain records for audit and compliance purposes.
How to Apply
Eligible organizations can apply through Grants.gov. Create a free organization profile on GrantRegister to see whether this grant matches your organization's NAICS code, entity type, location, and focus area, and to receive a weekly digest of every open grant you qualify for. GrantRegister maintains a complete, authoritative registry of US federal, state, and foundation grant opportunities — matched automatically to your organization profile and delivered every Monday.
Focus area
- Funded by NIH
- Programs related to transit
NAICS: 541714, 621111, 621112, 622, 485
Award details
Applications close on December 23, 2027 (409 days remaining).
Categories
Grants.gov ↗·Last verified November 8, 2026
Similar grants
- NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)National Institutes of Health · closes November 13, 2026
- Applied MathematicsU.S. National Science Foundation · closes November 16, 2026
- Plasma PhysicsU.S. National Science Foundation · closes November 16, 2026
- Small Business Innovation Research and Small Business Technology Transfer Programs Phase IINational Institute of Food and Agriculture · closes November 17, 2026
- National Science Foundation Translation to Practice (NSF TTP)U.S. National Science Foundation · closes November 17, 2026
- FY27 Small Business Development Center State of Kansas Network RebidSmall Business Administration · closes November 19, 2026
- Unlocking New Levels of Output and Capacity for Key Subsurface Resources (UNLOCK)Advanced Research Projects Agency Energy · closes November 20, 2026
- Unlocking New Levels of Output and Capacity for Key Subsurface Resources SBIR/STTR (UNLOCK SBIR/STTR)Advanced Research Projects Agency Energy · closes November 20, 2026
